X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (29375) 29375
Book Review (4041) 4041
Publication (1132) 1132
Newsletter (844) 844
Conference Proceeding (146) 146
Newspaper Article (128) 128
Book Chapter (66) 66
Magazine Article (60) 60
Dissertation (12) 12
Trade Publication Article (11) 11
Transcript (10) 10
Web Resource (5) 5
Book / eBook (4) 4
Data Set (2) 2
Report (2) 2
Government Document (1) 1
Presentation (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (24842) 24842
humans (23037) 23037
female (15431) 15431
methotrexate (14611) 14611
methotrexate - administration & dosage (13764) 13764
male (12311) 12311
middle aged (9796) 9796
adult (9708) 9708
aged (6893) 6893
antineoplastic combined chemotherapy protocols - therapeutic use (6707) 6707
methotrexate - therapeutic use (5911) 5911
oncology (5907) 5907
treatment outcome (5122) 5122
methotrexate - adverse effects (4238) 4238
chemotherapy (4091) 4091
cyclophosphamide - administration & dosage (3822) 3822
adolescent (3786) 3786
rheumatoid arthritis (3680) 3680
animals (3482) 3482
rheumatology (3452) 3452
arthritis, rheumatoid - drug therapy (3408) 3408
abridged index medicus (3399) 3399
drug therapy, combination (3365) 3365
child (3311) 3311
therapy (3124) 3124
cancer (2932) 2932
doxorubicin - administration & dosage (2863) 2863
fluorouracil - administration & dosage (2738) 2738
drug administration schedule (2694) 2694
care and treatment (2662) 2662
pharmacology & pharmacy (2528) 2528
vincristine - administration & dosage (2506) 2506
combined modality therapy (2331) 2331
drug therapy (2263) 2263
cisplatin - administration & dosage (2251) 2251
antineoplastic combined chemotherapy protocols - adverse effects (2206) 2206
prognosis (2200) 2200
retrospective studies (2154) 2154
dosage and administration (2125) 2125
time factors (2098) 2098
antirheumatic agents - therapeutic use (2088) 2088
child, preschool (2083) 2083
follow-up studies (2038) 2038
hematology (2009) 2009
research (1993) 1993
breast neoplasms - drug therapy (1966) 1966
dose-response relationship, drug (1955) 1955
pregnancy (1876) 1876
medicine & public health (1818) 1818
antineoplastic combined chemotherapy protocols - administration & dosage (1816) 1816
rheumatoid-arthritis (1666) 1666
risk factors (1657) 1657
double-blind (1646) 1646
antirheumatic agents - administration & dosage (1614) 1614
arthritis (1600) 1600
remission induction (1574) 1574
analysis (1520) 1520
prednisone - administration & dosage (1490) 1490
mice (1458) 1458
rats (1387) 1387
antineoplastic agents - administration & dosage (1386) 1386
prospective studies (1374) 1374
methotrexate - pharmacology (1371) 1371
health aspects (1361) 1361
children (1356) 1356
infliximab (1317) 1317
aged, 80 and over (1316) 1316
survival rate (1308) 1308
leucovorin - administration & dosage (1286) 1286
cytarabine - administration & dosage (1253) 1253
disease (1253) 1253
trial (1253) 1253
disease-free survival (1238) 1238
efficacy (1237) 1237
antirheumatic agents - adverse effects (1230) 1230
rheumatoid factor (1213) 1213
immunosuppressive agents - therapeutic use (1212) 1212
survival analysis (1157) 1157
patients (1150) 1150
pediatrics (1139) 1139
etanercept (1137) 1137
immunology (1123) 1123
administration, oral (1121) 1121
obstetrics & gynecology (1114) 1114
cyclophosphamide (1113) 1113
neoplasm staging (1108) 1108
clinical trials as topic (1107) 1107
dermatology (1104) 1104
toxicity (1096) 1096
chemotherapy, adjuvant (1091) 1091
antimetabolites, antineoplastic - administration & dosage (1090) 1090
precursor cell lymphoblastic leukemia-lymphoma - drug therapy (1083) 1083
medicine, general & internal (1065) 1065
etoposide - administration & dosage (1063) 1063
infant (1055) 1055
drugs (1044) 1044
doxorubicin (1042) 1042
young adult (1036) 1036
cisplatin (1026) 1026
diagnosis (1012) 1012
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (27312) 27312
Japanese (904) 904
German (614) 614
French (506) 506
Russian (275) 275
Spanish (203) 203
Chinese (166) 166
Polish (162) 162
Italian (127) 127
Hungarian (36) 36
Dutch (29) 29
Korean (25) 25
Danish (22) 22
Czech (20) 20
Portuguese (17) 17
Hebrew (15) 15
Norwegian (15) 15
Bulgarian (12) 12
Croatian (10) 10
Swedish (10) 10
Turkish (8) 8
Romanian (5) 5
Finnish (4) 4
Serbian (3) 3
Lithuanian (2) 2
Persian (2) 2
Slovak (2) 2
Estonian (1) 1
Greek (1) 1
Kurdish (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


British journal of cancer, ISSN 0007-0920, 2014, Volume 111, Issue 6, pp. 1072 - 1079
Background: Central nervous system (CNS) relapse in diffuse large B-cell lymphoma (DLBCL) is a devastating complication; the optimal prophylactic strategy... 
cytarabine | INTERMEDIATE-GRADE | FOLLOW-UP | diffuse large B-cell lymphoma | methotrexate intrathecal | CHEMOTHERAPY | central nervous system | RELAPSE | central nervous system prophylaxis | ONCOLOGY | STANDARD CHOP | NON-HODGKINS-LYMPHOMA | CNS PROPHYLAXIS | AGGRESSIVE LYMPHOMA | RITUXIMAB ERA | ELDERLY-PATIENTS | Recurrence | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Follow-Up Studies | Humans | Middle Aged | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Male | Central Nervous System Neoplasms - secondary | Young Adult | Central Nervous System Neoplasms - prevention & control | Aged, 80 and over | Vincristine - administration & dosage | Adult | Female | Acute Kidney Injury - chemically induced | Retrospective Studies | Doxorubicin - administration & dosage | Injections, Spinal | Prednisone - administration & dosage | Dexamethasone - administration & dosage | Lymphoma, Large B-Cell, Diffuse - drug therapy | Lymphoma, Large B-Cell, Diffuse - pathology | Risk Assessment | Rituximab | Etoposide - administration & dosage | Survival Rate | Cytarabine - administration & dosage | Disease-Free Survival | Methotrexate - adverse effects | Administration, Intravenous | Ifosfamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Adolescent | Methotrexate - administration & dosage | Aged | Index Medicus | intrathecal | methotrexate | Clinical Study
Journal Article
Annals of Oncology, ISSN 0923-7534, 03/2011, Volume 22, Issue 3, pp. 664 - 670
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 06/2014, Volume 370, Issue 25, pp. 2377 - 2386
In patients with rheumatoid arthritis, tofacitinib was associated with greater reductions in signs and symptoms than methotrexate. Herpes zoster infections and... 
MEDICINE, GENERAL & INTERNAL | MODIFYING ANTIRHEUMATIC DRUGS | RECOMMENDATIONS | COMBINATION THERAPY | JOINT DAMAGE | DISEASE | PLUS METHOTREXATE | DOUBLE-BLIND | RANDOMIZED-TRIAL | ETANERCEPT | CLINICAL-OUTCOMES | Herpes Zoster - etiology | Antirheumatic Agents - administration & dosage | Arthritis, Rheumatoid - blood | Cholesterol - blood | Humans | Middle Aged | Male | Protein Kinase Inhibitors - adverse effects | Arthritis, Rheumatoid - complications | Dose-Response Relationship, Drug | Janus Kinase 3 - antagonists & inhibitors | Arthritis, Rheumatoid - drug therapy | Pyrroles - administration & dosage | Antirheumatic Agents - adverse effects | Pyrroles - adverse effects | Adult | Female | Piperidines - administration & dosage | Double-Blind Method | Administration, Oral | Pyrimidines - administration & dosage | Methotrexate - adverse effects | Protein Kinase Inhibitors - administration & dosage | Piperidines - adverse effects | Pyrimidines - adverse effects | Creatinine - blood | Methotrexate - administration & dosage | Care and treatment | Dosage and administration | Tofacitinib | Comparative analysis | Methotrexate | Rheumatoid arthritis | Creatinine | Herpes zoster | C-reactive protein | Kinases | Joint diseases | E.S.R | Lymphoma | Sedimentation | Cholesterol | Pain | Rheumatism | Janus kinase | Drug therapy | Pharmaceuticals | Cancer | Index Medicus | Abridged Index Medicus
Journal Article
Blood, ISSN 0006-4971, 08/2013, Volume 122, Issue 7, pp. 1214 - 1221
From 2001 to 2011, 122 patients with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia were treated with chemotherapy + imatinib (n... 
ADULT PATIENTS | HYPER-CVAD | GENE REARRANGEMENTS | STANDARD-RISK | QUANTIFICATION | ACUTE LYMPHOBLASTIC-LEUKEMIA | FLOW-CYTOMETRY | STEM-CELL TRANSPLANTATION | HEMATOLOGY | MINIMAL RESIDUAL DISEASE | CLINICAL-SIGNIFICANCE | Piperazines - administration & dosage | Cyclophosphamide - administration & dosage | Prognosis | Follow-Up Studies | Humans | Middle Aged | Neoplasm Recurrence, Local - drug therapy | Male | Precursor Cell Lymphoblastic Leukemia-Lymphoma - mortality | Thiazoles - administration & dosage | Neoplasm Recurrence, Local - mortality | Young Adult | Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Benzamides - administration & dosage | Flow Cytometry | Neoplasm, Residual - diagnosis | Aged, 80 and over | Vincristine - administration & dosage | Adult | Female | Neoplasm, Residual - mortality | Philadelphia Chromosome | Real-Time Polymerase Chain Reaction | Doxorubicin - administration & dosage | Dasatinib | Prednisone - administration & dosage | Dexamethasone - administration & dosage | Pyrimidines - administration & dosage | RNA, Messenger - genetics | Survival Rate | Reverse Transcriptase Polymerase Chain Reaction | Imatinib Mesylate | Remission Induction | Cytarabine - administration & dosage | Neoplasm, Residual - genetics | Precursor Cell Lymphoblastic Leukemia-Lymphoma - genetics | Fusion Proteins, bcr-abl - genetics | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Methotrexate - administration & dosage | Neoplasm Recurrence, Local - genetics | Aged | Neoplasm Staging | Immunoglobulin Heavy Chains - genetics | Index Medicus | Abridged Index Medicus | Lymphoid Neoplasia
Journal Article
Lancet, The, ISSN 0140-6736, 2010, Volume 376, Issue 9757, pp. 2009 - 2017
Summary Background Although survival of children with acute lymphoblastic leukaemia has improved greatly in the past two decades, the outcome of those who... 
Internal Medicine | MEDICINE, GENERAL & INTERNAL | IDARUBICIN | THERAPY | DOSE ARA-C | PEDIATRIC-PATIENTS | SENSITIVITY | RISK | CHILDHOOD LEUKEMIA | EXPERIENCE | ACCELERATED APPROVAL | ONCOLOGY GROUP | Recurrence | Cyclophosphamide - administration & dosage | Humans | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Child, Preschool | Infant | Male | Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Vincristine - administration & dosage | Female | Leukocyte Count | Child | Idarubicin - therapeutic use | Mitoxantrone - therapeutic use | Dexamethasone - administration & dosage | Risk Assessment | Kaplan-Meier Estimate | Mercaptopurine - administration & dosage | Etoposide - administration & dosage | Treatment Outcome | United Kingdom | Vidarabine - analogs & derivatives | Cytarabine - administration & dosage | Polyethylene Glycols - administration & dosage | Asparaginase - administration & dosage | Disease-Free Survival | Antibiotics, Antineoplastic - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Adolescent | Methotrexate - administration & dosage | Vidarabine - administration & dosage | Complications and side effects | Dosage and administration | Acute lymphocytic leukemia | Drug therapy | Patient outcomes | Mitoxantrone hydrochloride | Studies | Design | Medical research | Chemotherapy | Cytogenetics | Cancer therapies | Data bases | Cancer | Ovarian cancer | Index Medicus | Abridged Index Medicus
Journal Article
Lancet, The, ISSN 0140-6736, 2016, Volume 387, Issue 10036, pp. 2402 - 2411
Summary Background Short intensive chemotherapy is the standard of care for adult patients with Burkitt's leukaemia or lymphoma. Findings from single-arm... 
Internal Medicine | MEDICINE, GENERAL & INTERNAL | CODOX-M/IVAC | CLEAVED-CELL LYMPHOMA | ACUTE-LYMPHOBLASTIC-LEUKEMIA | MULTIAGENT CHEMOTHERAPY | ADOLESCENTS | PLUS RITUXIMAB | NON-HODGKIN-LYMPHOMA | SURVIVAL RATE | PEDIATRIC-ONCOLOGY-SOCIETY | CHILDREN | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Injections, Intravenous | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Patient Selection | Burkitt Lymphoma - pathology | Hydrocortisone - administration & dosage | Vincristine - administration & dosage | Adult | Female | France | Odds Ratio | Burkitt Lymphoma - drug therapy | Doxorubicin - administration & dosage | Prednisone - administration & dosage | Drug Administration Schedule | Biomarkers, Tumor - analysis | Proportional Hazards Models | Treatment Outcome | Burkitt Lymphoma - diagnosis | Burkitt Lymphoma - chemistry | Cytarabine - administration & dosage | Rituximab - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Methotrexate - administration & dosage | Aged | Bone Marrow Neoplasms - drug therapy | Neoplasm Staging | Central Nervous System Neoplasms - drug therapy | Methylprednisolone - administration & dosage | Chemotherapy | Leukemia | Lymphomas | Adults | Epidemiology | Biometry | Cancer | Survival analysis | Biomedical research | Dehydrogenases | Medical prognosis | Clinical trials | Index Medicus | Abridged Index Medicus | Life Sciences
Journal Article
Cancer, ISSN 0008-543X, 12/2015, Volume 121, Issue 23, pp. 4158 - 4164
Durable remissions and long‐term survival can be achieved with a combination of chemotherapy and dasatinib in patients with Philadelphia chromosome‐positive... 
dasatinib | acute lymphoblastic leukemia | chemotherapy | combination | Philadelphia chromosome | ADULT PATIENTS | ACUTE LYMPHOCYTIC-LEUKEMIA | REGIMEN | HYPER-CVAD | PONATINIB | THERAPY | ONCOLOGY | IMATINIB | MRD | Doxorubicin - therapeutic use | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Follow-Up Studies | Cytarabine - therapeutic use | Humans | Middle Aged | Male | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - administration & dosage | Methotrexate - therapeutic use | Cyclophosphamide - therapeutic use | Neoplasm, Residual | Young Adult | Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Aged, 80 and over | Vincristine - administration & dosage | Adult | Female | Philadelphia Chromosome | Doxorubicin - administration & dosage | Dexamethasone - administration & dosage | Dasatinib - therapeutic use | Treatment Outcome | Cytarabine - administration & dosage | Precursor Cell Lymphoblastic Leukemia-Lymphoma - genetics | Dexamethasone - therapeutic use | Dasatinib - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Survival Analysis | Vincristine - therapeutic use | Methotrexate - administration & dosage | Aged | Dasatinib | Chemotherapy | Usage | Care and treatment | Lymphocytic leukemia | Stem cells | Dosage and administration | Transplantation | Diagnosis | Cancer | Index Medicus | Abridged Index Medicus
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 8, pp. 809 - 818
Journal Article
Cancer, ISSN 0008-543X, 12/2014, Volume 120, Issue 23, pp. 3660 - 3668
Retrospective analysis indicates that pediatric‐based therapy for acute lymphoblastic leukemia is superior to adult‐type therapy. This single institution... 
augmented Berlin‐Frankfurt‐Münster | pediatric‐based therapy | Philadelphia chromosome‐negative ALL | acute lymphoblastic leukemia | pediatric‐based regimens | Augmented Berlin-Frankfurt-Munster | Pediatric-based regimens | Acute lymphoblastic leukemia | Pediatric-based therapy | Philadelphia chromosome-negative ALL | ASPARAGINASE | pediatric-based therapy | pediatric-based regimens | PROGNOSTIC-FACTORS | PROTOCOLS | ACUTE LYMPHOCYTIC-LEUKEMIA | augmented Berlin-Frankfurt-Munster | RISK | INDUCTION | CANCER GROUP | CHILDHOOD | CHILDRENS ONCOLOGY GROUP | ONCOLOGY | MINIMAL RESIDUAL DISEASE | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prospective Studies | Humans | Induction Chemotherapy | Male | Consolidation Chemotherapy | Young Adult | Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Vincristine - administration & dosage | Adult | Female | Maintenance Chemotherapy | Daunorubicin - administration & dosage | Doxorubicin - administration & dosage | Dexamethasone - administration & dosage | Mercaptopurine - administration & dosage | Treatment Outcome | Cytarabine - administration & dosage | Asparaginase - administration & dosage | Thioguanine - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Adolescent | Methotrexate - administration & dosage | Cohort Studies | Index Medicus | Abridged Index Medicus
Journal Article